Table 1. The Prevalence of CTLA-4 +49A/G Polymorphism Among Patients With Clinical Presentation of VL who Were Seropositive for Leishmania (Group 1), Without Clinical Presentation but Seropositive (Group 2), and healthy controls (Group 3) a,b.
| Group 1 | Group 2 | Group 3 | |
|---|---|---|---|
| Genotypes | |||
| A/A | 33 (37.5) | 52 (60.5) | 48 (41.7) |
| A/G | 48 (54.5) | 22 (25.6) | 22 (19.1) |
| G/G | 7 (8) | 12 (14) | 45 (39.1) |
| Alleles | |||
| A | 114 (64.8) | 126 (73.3) | 118 (51.3) |
| G | 62 (35.2) | 46 (26.7) | 112 (48.7) |
a Abbreviations: A, adenine; G, guanidine.
b Data are presented as No. %